PRAC June 2025 Meeting Insights: What It Means & How Vigilare Biopharma Can Help
From Vigilare Biopharma: The recent PRAC meeting (2-5 June 2025) underscores the relentless pace of pharmacovigilance evolution. From gene therapy safety to AI integration and refined risk management for established classes, the demands on sponsors are intensifying. At Vigilare Biopharma, we specialize in transforming complex regulatory signals into actionable, compliant safety strategies.